Developing a physiological model for type II diabetes mellitus

Biochemical Engineering Journal

Volumn 55, Issue 1, 2011, Pages 7-16

  Vahidi, O ^a   Kwok, K E ^a   Gopaluni, R B ^a   Sun, L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Compartmental model; Dynamic simulation; Modeling; Nonlinear optimization; Parameter estimation; Type II diabetes mellitus

Indexed keywords

COMPARTMENTAL MODEL; DYNAMIC SIMULATION; MODELING; NON-LINEAR OPTIMIZATION; TYPE II DIABETES MELLITUS;

COMPUTER SIMULATION; GLUCOSE; OPTIMIZATION; PARAMETER ESTIMATION; PHYSIOLOGY; TISSUE;

PHYSIOLOGICAL MODELS;

GLUCOSE; INSULIN;

ARTICLE; COMPARTMENT MODEL; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HORMONE SYNTHESIS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 79955579594     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bej.2011.02.019     Document Type: Article

References (45)

1. National Diabetes Information Clearinghouse, Available at: http://diabetes.niddk.nih.gov/DM/PUBS/statistics/.
2. International Diabetes Federation. Diabetes Facts, Available at: http://www.idf.org/.
3. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992, 15:318-368.
4. Groop L.C., Widen E., Ferrannini E. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods. Diabetologia 1993, 36:1326-1331.
5. Basu A., Basu R., Shah P., Vella A., Johnson C.M., Nair K.S., Jensen M.D., Schwenk W.F., Rizza R.A. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism. Evidence for a defect in hepatic glucokinase activity. Diabetes 2000, 49:272-283.
6. Ferrannini E., Simonson D.C., Katz L.D., Reichard G., Bevilacqua S., Barrett E.J., Olsson M., DeFronzo R.A. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 1988, 37:79-85.
7. Campbell P.J., Mandarino L.J., Gerich J.E. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 1988, 37:15-21.
8. DeFronzo R.A., Ferrannini E., Simonson D.C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contribution of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989, 38:387-395.
9. Mitrakou A., Kelley D., Veneman T., Jenssen T., Pangburn T., Reilly J., Gerich J. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 1990, 39:1381-1390.
10. Fery F. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting. J. Clin. Endocrinol. Metab. 1994, 78:536-542.
11. Basu A., Alzaid A., Dinneen S., Caumo A., Cobelli C., Rizza R.A. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J. Clin. Invest. 1996, 97:2351-2361.
12. Consoli A., Nurjhan N., Capani F., Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1989, 38:550-556.
13. Alzaid A.A., Dinneen S.F., Turk D.J., Caumo A., Cobelli C., Rizza R.A. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J. Clin. Invest. 1994, 94:2341-2348.
14. Basu R., Schwenk W.F., Rizza R.A. Both fasting glucose production and disappearance are abnormal in people with mild and severe type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2004, 287:55-62.
15. Basu R., Chandramouli V., Dicke B., Landau B., Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 2005, 54:1942-1948.
16. Basu R., Basu A., Johnson C.M., Schwenk W.F., Rizza1 R.A. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes 2004, 53:2042-2050.
17. Basu A., Man C.D., Basu R., Toffolo G., Cobelli C., Rizza R.A. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care 2009, 32:866-872.
18. Iozzo P, Hallsten K., Oikonen V., Virtanen K.A., Kemppainen J., Solin O., Ferrannini E., Knuuti J., Nuutila P. Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. J. Clin. Endocrinol. Metab. 2003, 88:2055-2060.
19. Borra R., Lautamäki R., Parkkolaa R., Komu M., Sijens P.E., Hällsten K., Bergman J., Iozzo P., Nuutil P. Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 2008, 57:1445-1451.
20. Pfeifer M.A., Halter J.B., Porte D. Insulin secretion in diabetes mellitus. Am. J. Med. 1981, 7:579-588.
21. Polonsky K.S., Given B.D., Hirsch L.J., Tillil H., Shapiro E.T., Beebe C., Frank B.H., Galloway J.A., Cauter E.V. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1988, 318:1231-1239.
22. Luzi L., DeFronzo R.A. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am. J. Physiol. Endocrinol. Metab. 1989, 257:E241-E246.
23. Weyer C., Bogardus C., Mott D.M., Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest. 1999, 104:787-794.
24. Leahy J.L. Pathogenesis of type 2 diabetes mellitus. Arch. Med. Res. 2005, 36:197-209.
25. Guillausseau P.J., Meas T., Virally M., Laloi-Michelin M., Médeau V., Kevorkian J.P. Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab. 2008, 34:S43-S48.
26. World Health Organization, Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
27. Bolie V.W. Coefficients of normal blood glucose regulation. J. Appl. Physiol. 1961, 16:783-788.
28. Ackerman E., Gatewood L.C., Rosevear J.W., Molnar G.D. Model studies of blood-glucose regulation. Bull. Math. Biophys. 1965, 27(Suppl.):21-37.
29. Bergman R.N., Phillips L.S., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man. J. Clin. Invest. 1981, 68:1456-1467.
30. Cobelli C., Mari A. Validation of mathematical models of complex endocrine-metabolic systems. A case study on a model of glucose regulation. Med. Biol. Eng. Comput. 1983, 21:390-399.
31. Hovorka R., Canonico V., Chassin L.J., Haueter U., Massi-Benedetti M., Federici M.O., Pieber T.R., Schaller H.C., Schaupp L., Vering T., Wilinska M.E. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol. Meas. 2004, 25(4):905-920.
32. J.T. Sorensen, A physiological model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes, PhD Thesis, Massachusetts Institute of Technology, 1985.
33. Makroglou A., Li J., Kuang Y. Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview. Appl. Numer. Math. 2006, 56:559-573.
34. Mari A. Mathematical modeling in glucose metabolism and insulin secretion. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5:495-501.
35. ∞ glucose control in diabetes using a physiological model. AIChE 2000, 46:2537-2549.
36. Ramprasad Y., Rangaiah G.P., Lakshminarayanan S. Robust PID controller for blood glucose regulation in type I diabetics. Ind. Eng. Chem. Res. 2004, 43:8257-8268.
37. Hernandez-Ordonez M., Campos-Delgado D.U. An extension to the compartmental model of type 1 diabetic patients to reproduce exercise periods with glycogen depletion and replenishment. J. Biomech. 2008, 41:744-752.
38. Marchetti G., Barolo M., Jovanovic L., Zisser H., Seborg D.E. An improved PID switching control strategy for type 1 diabetes. IEEE Trans. Bio-Med. Eng. 2008, 55:857-865.
39. Farmer T.G., Edgar T.F., Peppas N.A. Effectiveness of intravenous infusion algorithms for glucose control in diabetic patients using different simulation models. Ind. Eng. Chem. Res. 2009, 48:4402-4414.
40. Guyton J.R., Foster R.O., Soeldner J.S., Tan M.H., Kahn C.B., Koncz L., Gleason R.E. A model of glucose-insulin homeostasis in man that incorporates the heterogeneous fast pool theory of pancreatic insulin release. Diabetes 1978, 27:1027-1042.
41. Landahl H.D., Grodsky G.M. Comparison of models of insulin release. Bull. Math. Biol. 1982, 44:399-409.
42. Rhoten W.B. Perifusion of saurian pancreatic islets and biphasic insulin release following glucose stimulation. Comp. Biochem. Physiol. 1973, 45(A):1001-1007.
43. Del Prato S., Matsuda M., Simonson D.C., Groop L.C., Sheeha P., Leonetti F., Bonadonna R.C., DeFronzo R.A. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 1997, 40:687-697.
44. Nielsen M.F., Basu R., Wise S., Caumo A., Cobelli C., Rizza R.A. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 1998, 47:1735-1747.
45. Nagasaka S., Tokuyama K., Kusaka I., Hayashi H., Rokkaku K., Nakamura T., Kawakami A., Higashiyama M., Ishikawa S., Saito T. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes 1999, 48:1054-1060.